Kerrisdale Advisers’s Chemours CC Stock Holding History

Kerrisdale Advisers’s Portfolio CC Stock Details CC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-52,401	Closed	-$1.15M	–	116
2026 Q1	$1.15M	Hold	52,401	–	–	0.44%	56
2025 Q4	$618K	Buy	52,401 +20,838	+66%	+$268K	0.29%	54
2025 Q3	$500K	Hold	31,563	–	–	0.26%	57
2025 Q2	$361K	Hold	31,563	–	–	0.19%	50
2025 Q1	$427K	Buy	31,563 +9,160	+41%	+$152K	0.18%	63
2024 Q4	$379K	Hold	22,403	–	–	0.13%	74
2024 Q3	$455K	Buy	+22,403	New	+$458K	0.15%	80
2023 Q4	–	Sell	-14,100	Closed	-$396K	–	87
2023 Q3	$396K	Buy	+14,100	New	+$484K	0.13%	79
2023 Q2	–	Sell	-15,255	Closed	-$457K	–	86
2023 Q1	$457K	Buy	+15,255	New	+$503K	0.14%	76
2020 Q3	–	Sell	-118,479	Closed	-$1.82M	–	68
2020 Q2	$1.82M	Hold	118,479	–	–	0.2%	53
2020 Q1	$1.05M	Buy	+118,479	New	+$1.71M	0.2%	46

Other funds holding CC

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

CCPM

Cooper Creek Partners Management New York $4.21B AUM 44.81% 1-Year Est. Return

VOYA Investment Management Atlanta, Georgia $116B AUM 61.47% 1-Year Est. Return

Kerrisdale Advisers's CC Position: Q2 2026 in Review

Kerrisdale Advisers sold out of Chemours (CC) in Q2 2026, closing a stake of 52,401 shares — an estimated $1.15M sold.

Kerrisdale Advisers first reported a position in CC in Q1 2020 and held it in 11 quarters. The position peaked at $1.82M in Q2 2020. 469 funds tracked by Wall St. Rank hold CC as of Q2 2026.

Kerrisdale Advisers reported no remaining Chemours position as of Q2 2026 after selling out during the quarter.
Kerrisdale Advisers sold 52,401 Chemours shares in Q2 2026, an estimated $1.15M.
Kerrisdale Advisers first reported a position in Chemours in Q1 2020 and held it in 11 quarters.
Kerrisdale Advisers's Chemours position peaked at $1.82M in Q2 2020.
469 funds tracked by Wall St. Rank held Chemours as of Q2 2026.

Based on Kerrisdale Advisers's 13F filing for Q2 2026, filed 14 Aug 2026.